A. Wells (London, United Kingdom), J. Grutters (Nieuwegein, The Netherlands)
Pulmonary function testing parameters and exercise capacity in subjects with scleroderma
A. Boutou, P. Siakka, T. Sfetsios, G. Pitsiou, I. Trigonis, E. Serasli, N. Chavouzis, P. Boura, P. Argyropoulou, I. Stanopoulos (Thessaloniki, Greece)
|  |
Intravenous cyclophosphamide therapy for patients with interstitial pulmonary disease associated with collagen vascular disorders. A single-center experience
M. Elshazly, A. Shahin, S. Alwakil (Cairo, Egypt)
| |
Cytomegalovirus antigenemina in idiopathic interstitial pneumonias and collagen vascular disease-related lung diseases treated with immunosuppressive drugs
T. Arai, Y. Inoue, K. Tachibana, J. Otsuka, K. Tsuyuguchi, S. Minamoto, M. Kitaichi, K. Suzuki, S. Hayashi, M. Oakada, M. Sakatani (Sakai City, Osaka, Japan)
| |
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicentered open-label study
A. Berezne, B. Ranque, D. Valeyre, M. Brauner, Y. Allanore, D. Launay, J. E. Kahn, L. J. Couderc, C. Joel, E. Hachulla, A. Kahan, J. Cabane, L. Guillevin, L. Mouthon (Paris, Bobigny, Lille, Suresnes, Bordeaux, France)
| |
Interstitial lung disease (ILD) associated with anti-PM/Scl and anti-aminoacyl-tRNA synthetase (ARS) autoantibodies: a similar condition?
J. C. Lega, V. Cottin, N. Fabien, J. F. Cordier (Lyon, France)
| |
The prognostic factors of cases with pulmonary involvement of rheumatoid arthritis at first discharge
K. Hashimoto, Y. Hasegawa, A. Yamasaki, N. Burioka, Y. Ueda, H. Nakazaki, T. Igishi, M. Watanabe, E. Shimizu (Tottori, Japan)
|  |
Rheumatoid arthritis-related lung disease
Y. Tsuchiya, N. Takayanagi, Y. Miyahara, D. Tokunaga, Y. Sugita, H. Sugiura, Y. Kawabata (Saitama, Japan)
| |
Novel markers of connective tissue disease in patients with idiopathic interstitial pneumonia
H. Gunawardena, Z. Betteridge, P. Owen, N. McHugh, N. Foley (Bath, United Kingdom)
| |
Study on collagen synthesis related factors in patients with idiopathic interstitial pneumonia
Z. Shu, W. Chen, D. Huaping, P. Baosen, M. Li (Beijing, China)
| |
Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic dermatomyositis and systemic sclerosis
H. Chiba, M. Otsuka, N. Hayashi, K. Kudo, S. Murakami, M. Shiratori, H. Takahashi (Sapporo/Hokkaido, Japan)
| |
Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis
W. R. Teodoro, A. P. Velasa, D. dos Anjos, R. Konno, C. C. de Oliveira, M. L. Katayama, E. R. Parra, N. Yoshinari, V. L. Capelozzi (São Paulo, Brazil)
| |
Interaction between vascular collagen V and endothelial apoptosis reinforce the vascular pathway in SSC pathogenesis
E. R. Parra, A. C. Aguiar, Jr., R. Gonçalves, W. R. Teodoro, W. T. de Souza, N. H. Yoshinari, V. L. Capelozzi (São Paulo, Brazil)
| |
Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis
A. C. Aguiar, Jr., E. R. Parra, S. D. M. Fernezliam, W. T. de Souza, D. P. Cuentas, V. L. Capelozzi (São Paulo, Brazil)
| |
Anti-a-enolase antibodies in systemic sclerosis identify a subset of patients with diffuse cutaneous sclerosis and interstitial lung disease
B. Terrier, M. Tamby, L. Camoin, A. Berezne, P. Guilpain, N. Tamas, M. Humbert, G. Simonneau, C. Broussard, L. Guillevin, L. Mouthon (Paris, Clamart, France)
| |
Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la
G. Margaritopoulos, K. Antoniou, G. Soufla, F. Economidou, C. Choulaki, A. Proklou, R. Lymbouridou, I. Lambiri, N. Tzanakis, N. Siafakas (Heraklion, Greece)
| |
The prevalence and subtypes of interstitial lung disease in polymyositis and dermatomyositis patients
R. Jenkins, H. Gunawardena, G. Robinson, N. McHugh, N. Foley (Bath, United Kingdom)
| |
Molecular diagnosis of the inherited disorders of surfactant homeostasis
R. Epaud, R. Aboutaam, L. Jaunard, M. Bahuau, M. Tredano, R. Couderc, J. De Blic, A. Clement, D. Feldmann (Paris, France)
| |
Yellow nail syndrome: analysis of 41 consecutive patients
F. Maldonado, H. Tazelaar, W. Chih-Wei, J. H. Ryu (Rochester, MN, Scottsdale. AZ, United States Of America; Taoyuan, Taiwan, Province Of China)
| |
Lenalidomid induced interstitial pneumonitis
S. Györik, J. Feichenfeldt, F. Quadri, E. Lerch (Bellinzona, Switzerland)
| |
Immunophenotypic profiles of lung carcinomas associated with idiopathic pulmonary fibrosis
M. Chilosi, S. Tomassetti, A. Dubini, A. Cavazza, G. Rossi, M. Kambouchner, A. Cancellieri, M. Barbareschi, S. Damiani, R. Carella, G. Pelosi, B. Murer, V. Poletti (Verona, Forlì, Reggio-Emilia, Modena, Bologna, Trento, Bolzano, Milan, Mestre, Ital
| |